Pfizer · Cash & Short-Term Investments

Latest reported$13.60Bperiod endingDec 31, 2025

PFE FY Cash & Short-Term Investments ($412.60M → $13.60B)

Annual Cash & Short-Term Investments

High-resolution chart · PNG

PFE cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer Cash & Short-Term Investments — Annual fiscal periods (USD)
Period ending	Cash & Short-Term Investments (USD)
Dec 31, 2025	13,596,000,000
Dec 31, 2024	20,477,000,000
Dec 31, 2023	12,690,000,000
Dec 31, 2022	22,732,000,000
Dec 31, 2021	31,069,000,000
Dec 31, 2020	12,223,000,000
Dec 31, 2019	9,646,000,000
Dec 31, 2018	18,833,000,000
Dec 31, 2017	19,992,000,000
Dec 31, 2016	17,850,000,000
Dec 31, 2015	23,290,000,000
Dec 31, 2014	36,122,000,000
Dec 31, 2013	32,408,000,000
Dec 31, 2012	32,399,000,000
Dec 31, 2011	26,452,000,000
Dec 31, 2010	28,012,000,000
Dec 31, 2009	25,969,000,000
Dec 31, 2008	23,731,000,000
Dec 31, 2007	25,475,000,000
Dec 31, 2006	27,713,000,000
Dec 31, 2005	22,226,000,000
Dec 31, 2004	19,893,000,000
Dec 31, 2003	11,952,000,000
Dec 31, 2002	12,551,000,000
Dec 31, 2001	8,615,000,000
Dec 31, 2000	6,863,000,000
Dec 31, 1999	6,386,000,000
Dec 31, 1998	1,552,000,000
Dec 31, 1997	877,000,000
Dec 31, 1996	1,150,000,000
Dec 31, 1995	403,300,000
Dec 31, 1994	1,458,500,000
Dec 31, 1993	729,400,000
Dec 31, 1992	1,257,100,000
Dec 31, 1991	1,317,600,000
Dec 31, 1990	870,300,000
Dec 31, 1989	825,400,000
Dec 31, 1988	807,500,000
Dec 31, 1987	1,031,100,000
Dec 31, 1986	398,600,000
Dec 31, 1985	412,600,000